Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Belanoff Joseph K
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
View:
Company
Corcept Therapeutics Inc.
Corcept Therapeutics Inc.
Chief Executive Officer, Director
Avg. Two Year Performance
No Purchase Track Record
(40%)
Avg. Sale Return
(19%)
Compound
Holdings:
2.83M
shares
Last Three Months: 25-Jan-24 -- 24-Apr-24
0
Net Amount
Buy:
0
--
Sell:
0
--
Sentiment
Company Sentiment
Biotechnology
Drugs
Two Year Chart
25-Apr-22 -- 24-Apr-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions